Multiple Sclerosis: Intravenous Immunoglobulin (IVIG)

Multiple Sclerosis: Intravenous Immunoglobulin (IVIG)

Topic Overview

Intravenous immunoglobulin (IVIG) is a medicine often used to boost the body's immune system and make it better able to fight disease. It is made from donated blood fluids.

Treatment with IVIG may improve function and lengthen the time before a relapse in people who have relapsing-remitting MS.1 It does not seem to help slow the progression of MS.2

IVIG can also lengthen the time before a second attack in people who take it after the first attack.1

But IVIG is extremely expensive, not widely available, and not considered practical for long-term treatment of MS. It sometimes may be used to treat a severe relapse if you either cannot take or do not respond to corticosteroids.

The safety of IVIG during pregnancy and breast-feeding is not known. Talk to your doctor if you are planning a pregnancy, if you are pregnant, or if you are breast-feeding.

Goodin DS, et al. (2002, reaffirmed 2008). Disease modifying therapies in multiple sclerosis: Report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines. Neurology, 58(2): 169–178.

This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.

The Health Encyclopedia contains general health information. Not all treatments or services described are covered benefits for Kaiser Permanente members or offered as services by Kaiser Permanente. For a list of covered benefits, please refer to your Evidence of Coverage or Summary Plan Description. For recommended treatments, please consult with your health care provider.